Fluoroquinolone (FQ) utilization in symptomatic bacteriuria (SB) due to E. coli and rate of FQ-resistant E. coli in a teaching psychiatric hospital by F Westphal & M Hittinger
POSTER PRESENTATION Open Access
Fluoroquinolone (FQ) utilization in symptomatic
bacteriuria (SB) due to E. coli and rate of FQ-
resistant E. coli in a teaching psychiatric hospital
F Westphal1,2*, M Hittinger3
From International Conference on Prevention & Infection Control (ICPIC 2011)
Geneva, Switzerland. 29 June – 2 July 2011
Introduction / objectives
There are still very few data available on antibiotic utili-
zation and bacterial resistance in the mental healthcare
setting. The present study examined the extent of FQ
utilization and the rate of FQ-resistant E. coli in SB in a
600-bed teaching psychiatric hospital.
Methods
SB data were reviewed by the Infection Control Unit over
a 5-year survey and compared across two inpatient popu-
lations, namely patients in long-term care (LTC) geriatric
wards (128 beds) and in acute general psychiatry (AGP)
wards (470 beds).
Results
Overall, 146 SB and 176 organisms were recorded in LTC
wards vs. 336 and 376 in AGP wards, respectively. E. coli
accounted for 55 % of urinary isolates in LTC wards vs.
68% in AGP wards (p<0.01). In AGP wards, there was no
significant trend (c²) in the year-to-year utilization of FQ
for treating SB (range 60%>75%) as well as in the rate of
FQ-resistant E. coli, rising from 12% to 15% over the
study period. In contrast, a significantÂ increase in the
rate of FQ-resistant E. coli causing SB (from 11% to 50%,
p<0.01) was seen in LTC wards over the study period
and was concomitant of a linear decrease (r=0.90,
p<0.05) in FQ utilization for treating SB in this setting.
This increasing resistance rate could be explained in part
by the high level of FQ utilization (74%) for treating SB
in the LTC wards during the first year of the survey; yet
other factors might be involved.
Conclusion
In this study, rate of FQ-resistant E. coli appeared rela-
tively low in the AGP wards despite the extensive use of
FQ. However, enhanced surveillance in LTC geriatric
wards seems required because of the risk of emerging
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